American Society of Hirudotherapy

Electrophoresis for the analysis of heparin purity and quality

Review published in Electrophoresis (2012)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewDrug DevelopmentVolpi N et al. · Electrophoresis, 2012

Abstract

The adulteration of raw heparin with oversulfated chondroitin sulfate (OSCS) in 2007-2008 produced a global crisis resulting in extensive revisions to the pharmacopeia monographs and prompting the FDA to recommend the development of additional methods for the analysis of heparin purity. As a consequence, a wide variety of innovative analytical approaches have been developed for the quality assurance and purity of unfractionated and low-molecular-weight heparins. This review discusses recent developments in electrophoresis techniques available for the sensitive separation, detection, and partial structural characterization of heparin contaminants. In particular, this review summarizes recent publications on heparin quality and related impurity analysis using electrophoretic separations such as capillary electrophoresis (CE) of intact polysaccharides and hexosamines derived from their acidic hydrolysis, and polyacrylamide gel electrophoresis (PAGE) for the separation of heparin samples without and in the presence of its relatively specific depolymerization process with nitrous acid treatment.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsChondroitin SulfatesDrug ContaminationElectrophoresisHeparin

Summary

The adulteration of raw heparin with oversulfated chondroitin sulfate (OSCS) in 2007-2008 produced a global crisis resulting in extensive revisions to the pharmacopeia monographs and prompting the FDA to recommend the development of additional methods for the analysis of heparin purity.

Why This Matters for Hirudotherapy

This review discusses recent developments in electrophoresis techniques, such as capillary electrophoresis and polyacrylamide gel electrophoresis, used for the sensitive separation and detection of contaminants in heparin following the 2007-2008 OSCS crisis. Maintaining stringent purity standards for biological anticoagulants is a shared priority, making these advanced analytical methodologies conceptually relevant to any research involving complex biological secretions like the leech secretome. The paper highlights how innovative analytical approaches can ensure the quality and safety of clinical anticoagulants. However, the article contains absolutely no mention of hirudotherapy, leeches, or leech-derived substances; its direct relevance is strictly limited to the analytical chemistry of heparin formulations.

Citation

Electrophoresis for the analysis of heparin purity and quality

Volpi N et al. · Electrophoresis, 2012

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.